Home » Authors » Trista Morrison

Articles by Trista Morrison

Acorda Raises $67 Million For Second Fampridine-SR Phase III

June 11, 2007

By Trista Morrison

Acorda Raises $67 Million For Second Fampridine-SR Phase III

June 11, 2007

By Trista Morrison

NewCo News: Viamet Gets $4 Million Series A For Targeting Metalloenzymes

June 11, 2007

By Trista Morrison

Amylin Sells $575 Million Of Convertible Senior Notes

June 7, 2007

By Trista Morrison

FDA Halts Telcyta Program On Heels Of ASCO Data

June 6, 2007

By Trista Morrison

FDA Halts Telcyta Program On Heels Of ASCO Data

June 6, 2007

By Trista Morrison

Telik Falls On Details Of Its Failed Phase III Telcyta Trials

June 5, 2007

By Trista Morrison

Telik Falls On Details Of Its Failed Phase III Telcyta Trials

June 5, 2007

By Trista Morrison

NewCo News: Indigo Licenses PAD Drug, Preps For Phase III Trials

June 4, 2007

By Trista Morrison

NewCo News: Indigo Licenses PAD Drug, Preps For Phase III Trials

June 4, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...